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Abbreviations
APA   American psychiatric association 
ADHD attention-deficit hyperactivity disorder 
SCN  suprachiasmatic nucleus 
CLOCK gene circadian locomotor output cycles kaput gene 
LC  locus coeruleus 
MSLT  multiple sleep latency test 
PSG  polysomnography 
ODD  oppositional defiant disorder 
CD  conduct disorder 
CBCL  child behavior checklist  
MEQ  morningness-eveningness questionnaire 
SOI  sleep onset insomnia 
DLMO dim light melatonin onset 
HPA axis hypothalamic-pituitary-adrenal axis 
CRF  corticotropin releasing factor 
RAS  reticular activation system 
DMH  dorsomedial hypothalamic nucleus 
VLPO area sleep-related ventrolateral preoptic area 
NE  noradrenaline 
PFC  prefrontal cortex 
DRD-4 gene dopamine receptor D4 gene 
fMRI  functional magnetic resonance imaging 
PET  positron emission tomography 
EEG  electroencephalogram 
ERP  event related potential 
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Abstract 
Disruptions in the sleep-wake cycle and the circadian system have been found in a 
wide range of psychiatric disorders and are generally correlated with clinical severity and 
diminished quality of life. Emerging evidence suggests similar disturbances may be found in 
attention deficit/hyperactivity disorder (ADHD). Here we review the available literature on 
across the day fluctuations in ADHD-related processes in terms of ; (i) time of day effects on 
behavior and activity; (ii) morningness-eveningness chronotypology; (iii) sleep/wake rhythms; 
and (iv) rhythmicity in neuroendocrine and neurophysiological responsiveness. On this basis, 
we propose a neurobiological framework to guide future study, which sees circadian effects in 
ADHD, along with other aspects of ADHD arousal-related deficits (e.g., cognitive energetic 
deficits), as being the result of dysregulated locus coeruleus function. Based on this 
perspective specific recommendations for future research are presented.   
Keywords: ADHD, arousal, circadian, suprachiasmatic nucleus, eveningness, behavior, 
sleep, melatonin, cortisol, heart rate, locus coeruleus 
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1. Introduction 
There is mounting evidence to support the notion that circadian rhythms are altered in 
a wide range of psychiatric diseases, especially affective disorders (see for reviews: Boivin, 
2000; Germain and Kupfer, 2008; McClung, 2007; Wirz-Justice, 2006). For example, 
impaired sleep and daytime fatigue are included in the diagnostic criteria for depressive 
disorders (American Psychiatric Association, APA, 2000) where diurnal variations in 
symptoms (e.g., mood and psychomotor activity) have frequently been reported. These 
fluctuations are reflected in physiological measures such that, compared to a control 
population, depressive patients show alterations in circadian rhythms of melatonin and 
(Pacchierotti et al., 2001) cortisol levels (Deuschle et al., 1997);  body temperature (Daimon 
et al., 1992);  and heart rate (Stampfer, 1998). Moreover, some interventions that change the 
timing of the biological clock in the brain (e.g., sleep deprivation, light therapy) have efficacy 
as treatments for these conditions (Wehr et al., 1979). For instance, Agomelatine, a new 
antidepressive agent with phase advancing characteristics has become available (Fornaro et al., 
2010; San and Arranz, 2008) and appears to be effective in at least a subgroup of patients 
(Duke, 2008). Diurnal variations in symptoms and altered profiles of circadian markers are 
also found in seasonal depressive disorder (Lewy et al., 2006), bipolar disorder (Harvey, 
2008), and schizophrenia (Rao et al., 1994).  
In attention deficit/hyperactivity disorder (ADHD) it is well established that 
behavioral symptoms and performance fluctuate both spontaneously over time and in 
response to changing environmental contexts (Antrop et al., 2005a; Luman et al., 2005; Power, 
1992; Sonuga-Barke et al., 1996; Toplak and Tannock, 2005; Wiersema et al., 2006b; Zentall 
and Zentall, 1976). In clinical practice, sleep-wake problems are frequently reported by 
individuals with ADHD or their parents, even though these problems are not currently 
included in the diagnostic criteria. As disruptions of circadian rhythms and sleep-wake cycles 
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are generally expected to have a significant impact on symptom severity (Fallone et al., 2001), 
daytime functioning (Bearpark and Michie, 1987), and health outcomes (Gangwisch, 2009; 
Scheer et al., 2009), in recent years, researchers have become increasingly interested in the 
possibility that such effects are implicated in ADHD pathophysiology. Gathering knowledge 
on diurnal variations in ADHD is important as these results may improve educational 
guidelines (such as optimal timing of academic lessons) and diagnostic and therapeutic 
assessments. For example, knowledge of time of day effects could lead to the adjustment of 
dosing and timing of ADHD medication to optimally observe and treat problematic behavior   
at a particular time of day. Furthermore, if findings on disrupted circadian rhythms are 
confirmed in ADHD, they may point to the value of circadian-based therapies in ADHD such 
as melatonin treatment and light therapy. To the best of our knowledge, there is no review that 
assesses findings on circadian effects in ADHD. 
 To date, the underlying mechanisms of circadian rhythm alterations in psychiatric 
disorders in general, or in some of these conditions specifically, are still unknown. The 
suprachiasmatic nucleus (SCN) in the ventral hypothalamus (Weaver, 1998) is thought to 
drive these 24-hour fluctuations in both physiological (e.g., body temperature, heart rate, 
hormone secretion) and psychological (cognitive performance, personality and behavior) 
functions (Carrier and Monk, 2000; Haus, 2007; Hofstra and de Weerd, 2008; Tankova et al., 
1994; Young, 2006). This biological clock has an endogenous nature - rhythms persist even in 
the absence of external, environmental information. However, exogenous cues, also called 
zeitgebers (e.g., light, but also sleep deprivation and social cues), tune this clock to a specific 
rhythm. The SCN is responsible for the functional time synchronization of all peripheral 
oscillators found in cells, tissues, and organs. Communication to peripheral structures takes 
place through both neural and endocrine factors, and enhances synchronized functioning of 
different human systems, including the central nervous system, the autonomic nervous system, 
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and the endocrine tissues (Haus, 2007). The sleep-wake cycle is also regulated by the SCN. 
However, this circadian process (process C) interacts with a homeostatic process (process S) 
to maintain wakefulness (which we further refer to as arousal; a physiological and 
psychological state of being awake, aware, and alert) during the day and to consolidate sleep 
at night. Whereas the process C is particularly important in the timing of sleep and arousal 
states, the process S regulates the duration and structure of sleep (Borbély, 1982). When 
considering the available evidence, disruptions in circadian rhythms and sleep-wake cycles 
have usually been related to changes in the timing of the biological clock (though alternative 
hypotheses have been provided; e.g., social zeitgeber theory, process S deficiency; Boivin, 
2000; Grandin et al., 2006). Alterations in biological clock timing have been seen as a 
consequence of changes in neurotransmitter activity related to the condition (Maurizi, 1984; 
Pacchierotti et al., 2001), but there is emerging research on circadian locomotor output cycles 
kaput (CLOCK) genes as an etiological factor (Barnard and Nolan, 2008).  
The current paper has two aims. First, to systematically review published data on 
across the day fluctuations in ADHD behavior, performance and physiological functioning in 
terms of ; (i) morningness-eveningness chronotypology; (ii) time of day effects of behavior 
and activity; (iii) sleep/wake rhythm problems; and (iv) rhythmicity in neuroendocrine and 
neurophysiological factors. Clinical implications of these (putative) effects will also be drawn 
out. Second, to develop a neurobiological framework to guide future research into circadian 
disruptions in ADHD. At the heart of this account is the hypothesis that disrupted circadian 
rhythms in ADHD, along with other arousal-related processes thought to be deficient in 
ADHD such as cognitive energetic problems, are due to locus coeruleus (LC) dysfunction.   
2. Review of Circadian Profiles in ADHD 
ADHD is one of the most prevalent psychiatric disorders in children and adolescents 
(Spencer et al., 2007), characterized by persistent problems in attention, hyperactivity and 
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impulsivity (APA, 2000). Based on the symptomatology, different ADHD subtypes can be 
distinguished namely the inattentive type, the hyperactive-impulsive type, and the combined 
(inattentive and hyperactive-impulsive) type. Although pervasiveness and persistence of 
symptoms and impairment are important criteria for the diagnosis of ADHD (APA, 2000), 
time- and context-dependent variability in behavioral symptoms and performance has been 
reported (Antrop et al., 2005a; Luman et al., 2005; Power, 1992; Sonuga-Barke et al., 1996; 
Toplak and Tannock, 2005; Wiersema et al., 2006b; Zentall and Zentall, 1976). Fluctuations 
in ADHD behavior have typically been explained in terms of either context-dependent acute 
changes in arousal state (both hypo- and hyperarousal; see section 3.2 and 3.3 for more 
detailed information), which in turn have been thought  to display spontaneous circadian 
effects across the day (see section 3.1 and 3.4 for more detailed information).  
2.1. Method 
An electronic literature search was performed using Web of Science and Pubmed 
(Medline) databases. Search terms were “circadian” or “diurnal” or “time of day” intersected 
with “ADHD” or “hyperactivity”. Based on the results of these strings, a more specific search 
was conducted using all combinations of previous terms with “eveningness” or “physical 
activity” or “sleep” or “melatonin” or “cortisol” or “heart rate”. A search through the 
references of original and related articles resulted in additional citations. Searches were 
restricted to papers in the English language published from 1967 to the present and included 
all studies with children, adolescents, and adults as participants. Since the “sleep” search 
string generated a lot of original articles and reviews, this paper focuses on findings with high 
relevance to the sleep-wake ‘rhythm’, i.e. results on sleep duration, sleep latency, and sleep 
efficiency as obtained by subjective and objective evaluation. The latter comprises 
investigations using either actigraph or multiple sleep latency test (MSTL). Polysomnography 
(PSG) research mainly focusing on sleep ’architecture’, e.g. REM and non-REM, and ADHD 
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has been thoroughly reviewed elsewhere (Cohen-Zion and Ancoli-Israel, 2004; Cortese et al., 
2009; Cortese et al., 2006; Sadeh et al., 2006) and is not reviewed again here.  
Because the literature directly related to circadian measures and ADHD is limited, 
studies using a single or short-term basal measurement of a circadian endocrine or autonomic 
variable were also included, even if they did not examine complete circadian patterns. 
However, studies including a basal pre-test measurement in the context of an experimental 
task were deemed to be less relevant for this review: These measurements could be influenced 
by anticipatory stress and have therefore only limited value in circadian evaluations. Time of 
day effects reported in behavioral studies were also considered, even if these primarily 
focused on contextual factors and not on 24-hour fluctuations. In addition, studies in patients 
with ADHD and comorbid disorders such as insomnia or disruptive behavioral disorders (i.e., 
oppositional defiant disorder (ODD) or conduct disorder (CD)) were reviewed although it is 
often difficult to disentangle the effects of the comorbid disorders from ADHD itself. 
2.2. Results 
The searches yielded studies using both subjective (e.g., questionnaires on 
chronotypology and sleep) and objective (e.g., endocrine measures, activity, and physiological 
registration) dependent measures. The majority of studies evaluated circadian rhythms in a 
naturalistic setting.  
2.2.1. Chronotypology. 
Chronotypology refers to a continuum on which individuals can be rated from high 
morning to high evening types (Cavallera and Giudici, 2008; Kerkhof, 1985; Tankova et al., 
1994).  The morningness-eveningness paradigm correlates highly with circadian rhythms and 
physiological measures of arousal (Baehr et al., 2000; Jankowski and Ciarkowska, 2008). We 
identified one paper in a general population of children and three papers in a clinical sample 
of adults with ADHD addressing this issue. In a healthy child population aged 8-13, Susman 
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et al. (2007) described an association between ADHD symptoms and distinctive patterns of 
circadian preference. The authors reported eveningness to be associated with higher scores on 
both attention problems and rule-breaking behavior in boys as measured by the Child 
Behavior Checklist (CBCL; Achenbach, 2001). In a clinical population of adults with ADHD, 
Rybak et al. (2007) found a circadian phase delay during the fall/winter period in adults with 
ADHD: They reported eveningness, as measured by the morningness-eveningness 
questionnaire (MEQ) (Horne and Ostberg, 1976), to correlate with both subjective (Brown 
Adult Attention Deficit Disorder Scale; Brown, 1996) and objective (Conners’ Continuous 
Performance Test; Conners, 2000) measures of attention deficits in ADHD. The association 
between eveningness and ADHD appeared to be independent of comorbid seasonal affective 
disorder. Caci et al. (2009) confirmed this relationship in adults suspected of having ADHD. 
Although inattention symptoms were strongly related to eveningness in their study, 
impulsivity and hyperactivity were not. Therefore, the authors suggested that eveningness 
may constitute an endophenotype of the predominantly inattentive subtype of ADHD. Also 
Bae et al. (2010) supported the idea that eveningness may be strongly associated with 
inattention problems in adult ADHD. Considering hyperactivity and impulsivity, they 
reported an association with eveningness in male subjects only. The link between ADHD and 
a later time of day preference (i.e., eveningness) is thought to reflect a delayed timing of 
optimal arousal levels. One possibility is that this differential across the day arousal pattern in 
ADHD is due to an altered 24-hour rhythmic control of the biological clock.  
2.2.2. Diurnal variations in behavior and performance. 
Behavioral observational research has provided overwhelming evidence for significant 
group differences between ADHD and controls in terms of mean levels of attention and 
activity measured across long periods of time. Although fluctuations in ADHD 
symptomatology and performance have been well studied in relation to changing 
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environmental demands (Antrop et al., 2005a; Luman et al., 2005; Power, 1992; Sonuga-
Barke et al., 1996; Toplak and Tannock, 2005; Wiersema et al., 2006b; Zentall and Zentall, 
1976), only seven studies have looked systematically at time of day effects (Table 1).  
<INSERT TABLE 1 ABOUT HERE> 
Observational studies: Zagar and Bowers (1983) reported a relationship between the 
hyperactive behavior of children with ADHD and time of day. During their observations 
(repeated 4-min periods once a week across four weeks), the authors found children with 
ADHD to be more inattentive and active in the afternoon. Recently, also Wehmeier et al. 
(2011) reported that the degree to which the various times of the day are found to be 
challenging fluctuates over the day. The authors investigated performance across different 
times of the day in children with ADHD receiving placebo or atomoxetine treatment. Though 
they found no indication of a differential treatment effect of the day, both groups showed a 
peak performance at 10 am which was followed by a decline with a trough at 2 pm; then 
performance improved again at 5 pm and declined toward the evening hours. The two studies 
described above could however not disentangle these findings from daily rhythms in attention 
(Lawrence and Stanford, 1999) and activity (Riddoch et al., 2007) in the normal population 
because they did not include a control group. Antrop et al. (2005b) investigated the influence 
of time of day on the effects of playtime on behavior in elementary school children with 
ADHD and normal developing classmates. They found an increase in hyperactive behavior in 
ADHD children only in the afternoon after controlling for several factors such as medication 
(see Table 1).  
Actigraph research: Analysis of activity in terms of its relative/absolute intensity has 
revealed distinctive time of day effects in ADHD.  Porrino et al. (1983) registered naturalistic 
activity levels in children with ADHD and control children during seven consecutive days. 
They reported that children with ADHD were more active than control children only during 
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specific hours of the school day (7 am, 8 am, 10 am, 11 am, noon, 2 pm, 3 pm, and 5 pm). 
However, the sample size in their study was small and direct observations were not performed. 
The authors tried to overcome this problem by keeping a diary of the children’s activities. 
They discovered that the hours of increased activity in children with ADHD coincided with 
structured school activities (reading and math classes), but not with recess/lunch periods. Also 
Tsujii et al. (2007) pointed to the possibility that time of day effects are likely to be 
confounded by context effects. They investigated the level of activity in different naturalistic 
educational settings, e.g., structured in-seat classes and non-structured classes at different 
times of day. Children with ADHD were significantly more active than controls during 
structured in-seat lessons in the afternoon, but no group differences were found during non-
structured classes, or during morning classes. More recently, Licht and Tryon (2009) found a 
significant group x time of day interaction effect in their naturalistic study investigating 
activity levels in a small group of children with ADHD and controls during one week. As 
hyperactivity in the ADHD group was only obvious during daytime and not during nighttime 
periods, the authors suggested that -along with contextual factors- circadian rhythms might 
play a role in these differential activity patterns. Similar findings were obtained in a larger 
sample by Imeraj et al. (2011). Moreover, their finding of higher daytime activity levels -
especially during noon and early afternoon hours- confirmed an important role for time of day 
effects in addition to environmental conditions in the expression of (afternoon) problem 
behavior in ADHD.  
2.2.3. Sleep-wake rhythms. 
Ten reviews on sleep patterns and ADHD in children and adults have already been 
published (Cohen-Zion and Ancoli-Israel, 2004; Cortese et al., 2009; Cortese et al., 2006; 
Gruber, 2009; Owens et al., 2009; Owens, 2005; Philipsen et al., 2006; Sadeh et al., 2006; van 
der Heijden et al., 2005a; Walters et al., 2008). In general, sleep studies in ADHD have given 
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mixed results on both subjective (i.e., clinical history, sleep diaries, and rating scales) and 
objective (i.e., actigraphy, and MSTL) sleep measures. The presence of different confounding 
factors in different studies have been suggested to be responsible for some of these 
discrepancies, e.g., age and sex (Boonstra et al., 2007), seasonal effects (Boonstra et al., 2007), 
temporal changes in DSM classification (Cortese et al., 2006), ADHD subtype (Wiggs et al., 
2005), medication status (Corkum et al., 1999; Cortese et al., 2006), and psychiatric 
comorbidity (Corkum et al., 1999; Cortese et al., 2006). The relation between ADHD and 
sleep becomes even more complex as sleep-related disorders such as restless leg syndrome 
and sleep apnea can present alongside ADHD (van der Heijden et al., 2005a). Primary sleep 
disorders may be a true comorbid condition with idiopathic ADHD, but some children may 
actually have a primary sleep disorder, misdiagnosed as ADHD, due to the fact that diurnal 
manifestations of primary sleep disorders can mimic ADHD symptoms (Chervin et al., 2002; 
Cortese et al., 2005). As this review focuses on the effect of circadian rhythms in ADHD, we 
concentrate here on circadian characteristics of the sleep-wake cycle, i.e., time of falling 
asleep, time of awakening, disturbed sleep phases, and daytime sleepiness, in children and 
adults with ADHD. As the timing of the sleep-wake cycle is controlled by the circadian 
pacemaker (i.e., the process C; Borbély, 1982), alterations in the timing of sleep and 
awakening could reflect an underlying circadian shift of the biological clock. Such disruption 
can cause significant daytime sleepiness, which is hypothesized to be more pronounced earlier 
in the day. However, daytime sleepiness and nighttime awakening could also reflect problems 
in the arousal-sleep “flip-flop” mechanism pointing to instability of the transition between 
sleep and wake, not necessarily related to specific times of day (Schwartz and Roth, 2008). 
For an overview of the 26 subjective and objective original papers included, see Table 2. 
<INSERT TABLE 2 ABOUT HERE> 
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Subjective evaluations: Nighttime parameters with high relevance to the sleep-wake 
rhythm include sleep onset, sleep duration, nighttime awakenings and difficulties with 
morning awakenings. Considering sleep onset difficulties and sleep onset latency, some 
studies report that children with ADHD show more difficulties initiating sleep or have longer 
sleep onset latency than normal controls (Hvolby et al., 2009; O'Brien et al., 2003a; O'Brien et 
al., 2003b; Owens et al., 2000), whereas other studies report sleep onset problems to be 
associated with ODD comorbidity and stimulant medication rather than ADHD itself 
(Corkum et al., 1999; Mick et al., 2000). Higher bedtime resistance in an ADHD population 
with ODD may exacerbate sleep complaints. However, an added effect of comorbid ODD on 
problematic behavior scores around bedtime was not confirmed by the study of Hvolby et al. 
(2009). As Owens et al. (2000) included unmedicated children with ADHD, stimulant 
medication could not be responsible for sleep onset latency problems reported in their study. 
With respect to total sleep duration, some authors reported no differences in sleep duration 
considering clinical samples of children with ADHD and normal controls (Hvolby et al., 2009; 
Marcotte et al., 1998; Mick et al., 2000), in contrast to other authors who reported both longer 
(Corkum et al., 2001) and shorter (Owens et al., 2000) sleep duration in ADHD. Several 
recent studies in larger population samples confirmed that short sleep duration is associated 
with problems related to attentional control and hyperactivity/impulsivity (Paavonen et al., 
2009; Pesonen et al., 2010; Touchette et al., 2009). In terms of sleep efficiency, some studies 
reported more nighttime awakenings in children with ADHD compared to normal controls 
(O'Brien et al., 2003a), whereas others found no differences (Hvolby et al., 2009; Mick et al., 
2000). Although some authors described more difficulties with morning awakenings (Chiang 
et al., 2010; Corkum et al., 2001; Owens et al., 2009), others found no support for this 
(Corkum et al., 1999; Mick et al., 2000; O'Brien et al., 2003a). With regard to daytime 
parameters, excessive daytime sleepiness has consistently been found to be more common in 
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children with ADHD compared to normal controls (Chiang et al., 2010; Cortese et al., 2009; 
O'Brien et al., 2003a; O'Brien et al., 2003b; Owens et al., 2009; Owens et al., 2000). To date, 
there are few studies of adolescents and adults. In adolescence, subjective severity of sleep 
problems was related to stimulant medication and comorbid depressive symptoms (Stein et al., 
2002), whereas in adults with ADHD, sleep problems such as sleep onset problems, 
difficulties with morning awakenings, and daytime sleepiness were reported to occur 
independent of stimulant medication and comorbidity (Schredl et al., 2007; Surman et al., 
2009). 
Objective evaluations: Actigraphy is a practical and accurate method to assess 
circadian rhythm disorders as actigraphic data can also be analyzed in terms of more general 
patterns of activity and rest as indicative of the sleep-wake cycle (Morgenthaler et al., 2007). 
Actigraphic studies in ADHD show mixed results (Cohen-Zion and Ancoli-Israel, 2004). 
Crabtree et al. (2003) found a delayed sleep onset in a group of children with ADHD referred 
to a sleep centre. As the authors included both medication treated and unmedicated children, 
results may be confounded by medication status. However, in unmedicated samples of 
children with ADHD (children discontinued medication or were medication naïve), shorter 
sleep duration (Owens et al., 2009) and longer sleep onset latency (Hvolby et al., 2008) have 
been confirmed as compared to controls. Nevertheless, sleep onset latencies have been shown 
to increase following stimulant medication in multiple (placebo-controlled) studies (Corkum 
et al., 2008; Ironside et al., 2010; Schwartz et al., 2004). For example, Barkley et al. (1990) 
found 15% of their subjects with ADHD experiencing insomnia during the placebo condition 
and more than 50% in the methylphenidate condition. Beneficial effects of medication on 
some aspects of sleep such as nighttime awakenings and parasomnias have also been reported 
(Kim et al., 2010).  
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Not all studies using objective measures have found differentiating sleep-wake results 
in ADHD (Corkum et al., 2001; Dagan et al., 1997; Gruber et al., 2000). One explanation for 
this inconsistency is that higher night-to-night variability accounts for similar mean sleep 
estimates in ADHD and control groups, despite the fact that standard deviations are 
significantly different between groups (Crabtree et al., 2003; Gruber et al., 2000; van der 
Heijden et al., 2005a). Another possibility is that sleep/wake findings are only applicable to a 
specific subgroup of children with ADHD as Van der Heijden et al. (2005b) reported different 
findings in ADHD with a comorbid sleep disorder and ADHD without sleep problems. A 
subgroup of children with ADHD and comorbid chronic sleep onset insomnia (SOI) disorder, 
compared to children with ADHD without sleep problems, showed a delayed sleep onset (on 
actigraphy) together with a delayed onset of the nocturnal melatonin peak (dim light 
melatonin onset, DLMO). As no control group was included in this study, one cannot be 
certain to what extent ADHD with or without SOI would differ from controls. Parallel 
findings have recently been obtained in adults with ADHD and SOI (significant differences 
between ADHD with and without SOI; Van Veen et al., 2010). However, the authors also 
included a normal control group from which both ADHD+SOI and ADHD-SOI differed in 
sleep onset latency and sleep efficiency. Similarly, Boonstra et al. (2007) reported that adults 
with ADHD (irrespective of SOI) take longer to fall asleep, have lower sleep efficiency, and 
shorter within-night periods of uninterrupted sleep compared to normal controls. It is possible 
that the biological clock influencing the timing of sleep-wake cycles is set to a later time in 
children with ADHD as compared to controls. The DLMO additionally reflects this delayed 
sleep timing. The use of melatonin as a marker for circadian evaluation and the effect of 
melatonin treatment to reset the circadian clock in ADHD are discussed below.  
Two studies using the MSLT reported significantly more daytime sleepiness in 
children and adolescents with ADHD than in controls (Golan et al., 2004; Lecendreux et al., 
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2000). This means that subjects with ADHD have shorter sleep onset latency during one or 
more daytime naps. Although children with ADHD were more sleepy throughout the day, 
Golan et al. (2004) observed the most severe sleepiness was in the morning (8 AM). This 
finding is consistent with a delayed circadian rhythm in ADHD. In a driving simulation 
experiment, similar results were obtained in adult drivers with ADHD: They were more 
susceptible to fatigue earlier in the day (Reimer et al., 2007).  
Altogether, a majority of studies on sleep-wake rhythms support a delayed sleep phase 
syndrome, suggestive of a disruption of the 24-hour sleep/arousal control, in (at least a 
subgroup of) subjects with ADHD. Several factors may have confounded these results (see 
Table 2 for more detailed study-specific information). However, a recent meta-analysis by 
Cortese et al. (2009), controlling for medication status and comorbidity, confirmed more sleep 
onset difficulties, night awakenings, difficulties with morning awakenings, higher sleep onset 
latency and lower sleep efficiency in children with ADHD (irrespective of comorbid SOI 
diagnosis). These characteristics provide additional support for the hypothesis of a delayed 
sleep phase syndrome in ADHD. As this meta-analysis did not consider other confounding 
factors (e.g., comorbid anxiety or depression, stress, difficulty settling down), it needs to be 
further determined to what extent these problems are specific to ADHD (or at least to a 
subgroup of ADHD). To address these issues a transdiagnostic approach has been proposed in 
the treatment of insomnia across a variety of psychiatry disorders (Harvey et al., 2011).  This 
approach could be especially useful in relation to ADHD given that SOI problems occur in up 
to 54% of ADHD cases affecting daily functioning and quality of life (Tjon Pian Gi et al., 
2003). 
2.2.4. Circadian effects on neuroendocrine and neurophysiological processes. 
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To date, research using neuroendocrine (e.g., cortisol) and neurophysiological (e.g., 
heart rate) measures in ADHD are mainly laboratory-based. However some data from more 
naturalistic studies measuring across the day changes is available.    
2.2.4.1. Melatonin.  
Melatonin is an  interesting hormonal marker used in the evaluation of circadian 
rhythms which affects the circadian regulation of different biological functions, including the 
sleep-wake cycle. Melatonin production by the pineal gland and the retina occurs at night 
such that concentrations are very low during daytime, increase at nightfall (DLMO) and peak 
around 3-4 am (Haus, 2007). DLMO production is the most reliable marker of circadian phase 
position (Hofstra and de Weerd, 2008; Klerman et al., 2002; Van der Heijden et al., 2005b; 
see also Macchi and Bruce (2004), Claustrat et al. (2005), and Benloucif et al. (2008) for a 
more detailed description of melatonin regulation, secretion, and analysis).  
Deviant melatonin levels have been related to several psychiatric disorders including 
depression, mania (Crasson et al., 2004; Kennedy et al., 1996), and seasonal affective disorder 
(Lewy et al., 2006). Very recently, Chaste et al. (2011) provided the first genetic 
ascertainment of defects in the melatonin pathway of patients with ADHD. Two studies have 
examined endogenous melatonin rhythms in children with ADHD and there is one study in 
adults (see also Table 2). Compared to control subjects, Nováková et al. (2011) did not report 
different 24-h melatonin profiles in their group of children with ADHD (6-12y). However, 
when considering younger and older subgroups separately, subtle developmental differences 
were revealed: i.e., in the oldest children with ADHD (10-12 y) only the onset, but not the 
offset, phase delayed with increasing age. In their group of children with ADHD (6-12 y), 
Van der Heijden et al. (2005b) reported that 73% of subjects met the criteria for sleep onset 
insomnia. Based on the measurements of activity levels and DLMO, they found evidence for 
a delayed sleep phase syndrome, i.e. longer sleep onset, later wake-up time, and delayed 
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DLMO (Nagtegaal et al., 1998), in their subgroup of children with ADHD and comorbid 
chronic SOI compared to the group with ADHD without sleep problems. This has been 
confirmed in adults with ADHD+SOI compared to adults with ADHD-SOI and normal 
controls (Van Veen et al., 2010). The therapeutic use of exogenous melatonin (5 mg 
melatonin in the evening), used to reset the timing function of the SCN, is associated with 
advanced sleep onset and DLMO compared to placebo in children with idiopathic chronic 
sleep-onset insomnia (Smits et al., 2001; Smits et al., 2003). Also in children with ADHD, 
melatonin administration is considered to be an effective treatment of initial SOI (Bendz and 
Scates, 2010). Significant improvement in sleep parameters such as sleep onset and sleep 
onset latency were described in both non-stimulant treated (Hoebert et al., 2009; Van Der 
Heijden et al., 2007) and stimulant treated (Tjon Pian Gi et al., 2003; Weiss et al., 2006) 
children with ADHD and insomnia. Although melatonin resets the circadian timing system, 
no effect of melatonin on daytime behavior symptoms could be observed in the study of Van 
der Heijden et al. (2007). In contrast, parents stated that melatonin was not only effective for 
sleep onset insomnia, but also for behavior problems in the 3-year follow-up assessment of 
this sample (Hoebert et al., 2009).  
2.2.4.2. Cortisol. 
The hypothalamic-pituitary-adrenal (HPA) axis is also sensitive to time information 
from the SCN (Haus, 2007), which is reflected in a typical diurnal cortisol pattern with a 
trough (the nadir) around midnight. In normal subjects, cortisol concentrations gradually 
increase 2 to 3 hours after bedtime, with a peak (the acrophase) 30 to 45 minutes after 
awakening, i.e., the cortisol awakening response. Levels then decrease gradually to nighttime 
concentrations (Buckley and Schatzberg, 2005; Edwards et al., 2001). Cortisol level in saliva 
is a reliable peripheral measure of arousal (see also Levine et al. (2007) for a review on the 
analysis of cortisol).  
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With respect to ADHD, cortisol levels have mostly been measured in response to 
stress (Hong et al., 2003; Randazzo et al., 2008; Shin and Lee, 2007; Snoek et al., 2004; van 
West et al., 2009), although a few attempts have been made to evaluate the influence of time 
of day. Although most of the stress response studies also describe basal cortisol levels on a 
single pre-stress measurement, results on this measure are inconsistent and have only limited 
value in the evaluation of diurnal cortisol patterns. Intra- and inter-day variability in 
individual cortisol patterns requires an evaluation using repeated cortisol measures across 
several days (Bartels et al., 2003; Edwards et al., 2001; Houtveen and de Geus, 2009; Schulz 
et al., 1997). To our knowledge, such an ‘ideal’ investigation has only been applied in one 
study (Imeraj et al., 2012). We therefore include studies with multiple measurements across 
one day (combined morning and basal sampling), but also studies including awakening or 
basal samples only. For an overview of the thirteen studies considered, see Table 3. 
<INSERT TABLE 3 ABOUT HERE> 
Most studies of diurnal patterns of cortisol have found a relationship between ADHD 
symptoms and altered circadian cortisol patterns. Results are inconsistent however showing 
both hypo- and hyperarousal deviations at different time points. Considering studies with 
repeated measurements across one day, Kaneko et al. (1993) originally found a normal diurnal 
cortisol pattern in only 43.3 % of the children with ADHD, suggesting a dysregulation of the 
HPA axis in the majority of children. Though Pesonen et al. (2011) could not find an 
association beween ADHD symptoms and diurnal cortisol profile in 8-year old children from 
the general population, other authors did. In a slightly older population sample, Susman et al. 
(2007) reported a small morning-to-afternoon cortisol ratio in boys -but not girls- with 
attention problems, which suggests an atypical circadian rhythm. Also Sondeijker et al. (2007) 
reported ADHD problems to be associated with higher basal evening cortisol levels in a 
general child population sample. However, they reported the opposite effect of sex of child 
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compared to Susman et al. (2007) with high rates of ADHD problems being associated with 
higher awakening cortisol levels in boys, but not in girls. Studies considering only awakening 
values also suggested a dysregulation of the HPA axis in ADHD, although findings were 
inconsistent. Some authors found a lower cortisol awakening response in a group of children 
with ADHD compared to a group of controls (Blomqvist et al., 2007; Ma et al., 2011), 
whereas Hatzinger et al. (2007) found higher morning peak levels in a much younger 
population sample of boys with hyperactivity symptoms. In contrast to previous findings, two  
recent studies failed to find any difference on morning cortisol between children with ADHD 
(without comorbid disorders) and control children (Freitag et al., 2009; Wang et al., 2011). 
Only one study has examined this in adults which reported no effect of ADHD diagnosis 
(Hirvikoski et al., 2009): Both the overall cortisol levels and the typical diurnal cortisol 
rhythm, including the awakening response, were normal in ADHD. 
Considering the high comorbidity rates of ODD in ADHD, inconsistent results may be 
explained by confounding effects of ODD. According to the hypo-arousal theory (Quay, 1965; 
Raine, 1996), disruptive disorders such as ODD and CD are linked to lower basal cortisol 
levels and lower stress responses  (McBurnett et al., 2000; Moss et al., 1995; van Goozen et 
al., 2000; van Goozen et al., 1998), but also to lower morning values (Pajer et al., 2001; 
Shirtcliff et al., 2005). Results relating to ADHD with comorbid ODD/CD are inconsistent. 
Some authors confirmed a hypo-arousal pattern in children with ADHD+ODD measuring 
both awakening (Freitag et al., 2009) and basal values (Kariyawasam et al., 2002) while other 
authors failed to find any robust association between waking levels and comorbid problems in 
ADHD (Hastings et al., 2009). In line with these findings, no differences in basal levels 
between ADHD children with aggression and without aggression have been reported (Schulz 
et al., 1997), suggesting the possibility that certain characteristics of ADHD, rather than 
aggression, could be associated with cortisol levels. Very recently, this complex relation 
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between ADHD-ODD comorbidity and diurnal cortisol profiles has become a focus of interest. 
In the study of Imeraj et al. (2012), salivary cortisol was sampled five times a day (awakening, 
30 min after awakening, noon, 4PM, 8PM). Their findings supported time-related arousal 
disruptions in children with ADHD associated with the presence or absence of ODD 
comorbidity. More specifically, it seemed that the ADHD subgroup without ODD 
comorbidity showed a flatter slope with relative morning hypo-arousal and evening 
hyperarousal, whereas the ADHD+ODD subgroup showed a steeper slope with relative 
morning hyperarousal and evening hypo-arousal.  
2.2.4.3. Heart rate. 
As arousal involves activation of the autonomic nervous system, physiological 
dysregulation of this system could be related to several psychiatric disorders involving arousal 
problems (Dietrich et al., 2007; Lorber, 2004; Ortiz and Raine, 2004). For example, a relation 
between low basal heart rate and disruptive behaviors has been established by several authors 
(Lorber, 2004; Mezzacappa et al., 1997; Ortiz and Raine, 2004). However, results on 
autonomic functioning in ADHD are less clear. Moreover, studies focusing on full circadian 
patterns are still limited despite the well-known time of day effects in heart rate. Recently, 
normal intrinsic circadian rhythms have been described (Waterhouse et al., 2007): an average 
day-night difference in resting heart rate of 6.5 bpm has been replicated by several authors 
(Burgess et al., 1997; Kerkhof et al., 1998; Scheer et al., 2003).  
Research in relation to ADHD has mainly focused on specific laboratory conditions 
such as stress inducing performance (Lackschewitz et al., 2008), peer provocation 
(Waschbusch et al., 2002), performance (Borger and van der Meere, 2000; Crone et al., 2003), 
and reward (Beauchaine et al., 2001; Crone et al., 2003; Crowell et al., 2006; Iaboni et al., 
1997; Luman et al., 2007). Pre-test heart rate usually did not differ between subjects with 
ADHD and normal controls (Iaboni et al., 1997; Lackschewitz et al., 2008). However, these 
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levels may be influenced by anticipatory stress and studies have tended not to investigate time 
of day fluctuations in ADHD. Only recently, a study on 24-hour heart rate patterns in ADHD 
has been completed (Imeraj et al., 2011).  
Crowell et al. (2006) reported lower basal heart rate (pre-test value) in children with 
ADHD+ODD. Herpertz et al. (2001) compared ADHD groups with and without comorbid CD 
- they reported lower autonomic responses in the comorbid but not in the ADHD-only group, 
relative to controls. Although non-specific skin conductance responses were significantly 
different between groups in this study, this was not the case for resting heart rate levels. In 
contrast, van Lang et al. (2007) reported a higher mean basal heart rate (measured between 1 
pm and 5 pm) in a group of children with high scores on ADHD+CD/ODD compared to a 
group with ADHD without comorbidity. These results suggest that differences in basal heart 
rate and autonomic functioning could be due to confounding effects of comorbidity, 
medication, and time of day.  
Recently, Tonhajzerova et al. (2009) found that unmedicated children with ADHD 
without comorbid disorders were more likely to display tachycardia compared to normal 
controls during a short-term evaluation (3 intervals of 5 minutes) in both supine position and 
orthostasis. These measurements were conducted between 8 AM and noon. Although this 
study was limited by a small sample and possible confounding effects of stress in a laboratory 
setting, spectral analysis of these results indicated changes in the cardiac autonomic regulation, 
i.e., decreased cardiac vagal modulation in supine position and altered ability of dynamic 
activation of the autonomic nervous system in response to orthostasis. It has been 
hypothesized that such an autonomic imbalance -low parasympathetic activity and a relative 
sympathetic dominance- reflects low heart rate variability, a marker for prefrontal hypo-
activity (Thayer and Sternberg, 2006) as seen in ADHD (Arnsten, 1998; Halperin and Schulz, 
2006; Himelstein et al., 2000; Valera et al., 2007). Very recently, the finding of higher heart 
CIRCADIAN PROFILES IN ADHD  23 
 
rate levels in non-medicated children with ADHD was confirmed during a 5-day heart rate 
registration study (Imeraj et al., 2011). Additional analyses revealed that group effects were 
larger at specific times of the day, namely afternoon and nighttime hours; a finding 
independent of activity and comorbid psychiatric disorders. The authors suggested that time 
of day may be an important contributor to altered heart rate patterns in ADHD. Especially the 
increase in nighttime levels, i.e., resting heart rate, seems important as this measure refers to a 
lower vagal tone which is associated with cardiovascular disease and mortality (Thayer and 
Lane, 2007). 
2.2.5 Summary of findings, limitations and clinical implications of research to 
date.  
Although patchy and inconsistent, this review found initial support for disrupted 
circadian rhythms in ADHD with respect to each area reviewed. First, a circadian phase delay 
was suggested in (at least a subgroup of) subjects with ADHD. This evidence was clearest in 
relation to chronotypology and sleep-wake rhythms, pointing to an association of ADHD with 
self-reported optimal arousal later in the day (i.e., eveningness) and with later sleep times, 
difficulties with morning awakenings, and excessive daytime sleepiness earlier in the day. 
The idea that the biological clock is responsible for this delayed timing of sleep-arousal states 
in ADHD was further supported by melatonin studies showing a delayed DLMO in a 
subgroup of subjects with ADHD and chronic SOI, which improved after melatonin treatment.  
Second, on the behavioral level, studies supported time of day effects in attention, 
performance, and activity. However, group differences were particularly expressed during 
afternoon hours, which runs counter to the previously hypothesized circadian phase delay. 
One possibility is that optimal arousal levels in children with ADHD are set at later times of 
the day as compared to controls, but both still occur in the morning/noon rather than the 
afternoon. Alternatively, more overt problematic behavior could be the result of a complex 
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interaction between specific times of day (especially afternoon) and contextual conditions 
(e.g., high cognitive, self-regulatory demands).  
Finally, published data on across the day fluctuations in cortisol and heart rate, 
although inconsistent, provide some additional support for this point of view. With respect to 
cortisol, most data support differential diurnal cortisol patterns in ADHD, but the specific 
time points (awakening vs evening) responsible for this circadian effect could not been 
established. Very recently, the evaluation of diurnal cortisol patterns during multiple days 
revealed that ADHD with or without ODD subgroups may be hypo- versus hyperaroused at 
different times of the day (Imeraj et al., 2012). Despite well-established across the day 
fluctuations in heart rate in normal populations, in ADHD, this measure has mostly been 
examined in relation to stress without taking into account possible time of day effects. There 
is only one longer-term evaluation of heart rate in ADHD. In this study, children with ADHD 
showed higher heart rate levels which were particularly expressed during the night and the 
afternoon, suggesting that circadian effects are important in explaining autonomic dysfunction 
in ADHD (Imeraj et al., 2011).  
These results must be interpreted in the light of study limitations. First, most of the 
studies were not designed to investigate time of day effects in ADHD and so the results may 
be confounded by factors that influence the endogenous biological clock function. Potential 
confounders include; (i) environmental factors such as light, climate and latitude; (ii) 
developmental factors such as age, sex, pubertal stage, menstrual cycle stage; (iii) factors 
related to health status (including tobacco use, caffeine intake, and alcohol consumption) and 
disease characteristics (including ADHD severity, subtype, comorbidity, and medication 
status); and (iv) factors as stress, digestion, motivation, and physical exercise (Atkinson et al., 
2007; Blatter and Cajochen, 2007; Carskadon et al., 1993; Cortese et al., 2006; Portaluppi et 
al., 2008).  
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Second, studies have typically used a small number of measures evaluated during 
relative short observation periods. This limits the interpretability and generalizability of 
results across biological and psychological systems. In circadian research, combinations of 
measures have been suggested to be important as interactions and common pathways between 
several circadian markers have been described. For example, there is a mutual link between 
the autonomic nervous system and the HPA axis: sympathetic activation results in higher 
production of CRF and therefore, also of cortisol; inversely, corticotropin releasing factor 
(CRF) stimulates noradrenergic neurons (Chrousos and Gold, 1998; Sondeijker et al., 2007). 
Also interactions between melatonin and cardiovascular function (Scheer et al., 2003; 
Zawilska et al., 2009), between melatonin and body temperature (Zawilska et al., 2009) and 
between HPA axis functioning and sleep patterns have been reported (Buckley and 
Schatzberg, 2005; Edwards et al., 2001). High inter- and intra-day variability in these 
circadian measures warrants longer-term evaluations (Bartels et al., 2003; Edwards et al., 
2001; Houtveen and de Geus, 2009; Schulz et al., 1997).  
Finally, previous research does not assess which mechanisms may underpin the 
association of disrupted circadian rhythms and ADHD and does not allow inferences to be 
drawn about the causal role of such circadian effects. On the one hand, a delayed timing of 
sleep-arousal states by the SCN seems to be important in subjects with ADHD. Though this 
finding could probably not be generalized to all subjects, considering the heterogeneous 
nature of ADHD, a disrupted circadian regulation of arousal could aggravate ADHD 
symptoms or could even represent a specific developmental pathway in at least some cases. 
On the other hand, in general, arousal dysregulation in ADHD seems to be associated with a 
more complex pattern of behavioral problems throughout the day, which are even more 
expressed in interaction with environmental and stress-related events.    
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Despite inconsistencies in studies and methodological limitations the emerging 
evidence for circadian effects may eventually have practical value. For example, children with 
ADHD and comorbid insomnia (aged 6-14) were reported to benefit from exogenous 
melatonin administration -with or without combined stimulant medication treatment. It may 
therefore be valuable to routinely evaluate sleep problems in ADHD  to detect this subgroup 
and improve their outcomes. Although light therapy seems effective in adults with ADHD and 
a delayed sleep phase (Rybak et al., 2004), so far, no melatonin medication studies in this 
population are available. Well-designed studies to establish optimal dosing regimens for 
different age groups and long-term safety are needed (Bendz and Scates, 2010).  
Identifying the afternoon as a period of risk for ADHD (especially when there is an 
overlap with high environmental demands) may encourage further educational adaptations 
considering the timing of academic lessons. Relatedly, adjustment of dosing and timing of 
ADHD medication to optimally observe and treat problematic behavior considering its 
fluctuating expression should be considered. Systematic methods of assessment of time of day 
effects for clinical purposes need to be developed (Chavez et al., 2009; Pelham et al., 2001; 
Sonuga-Barke et al., 2004; Swanson et al., 2004). Though the specific mechanisms that may 
underpin time of day effects in arousal dysregulation are still unknown, such knowledge may 
guide specific therapeutic choices for individual patients as arousal levels are often the target 
of focus for interventions. For example, according to Stadler et al. (2008), children with a 
lower basal heart rate, i.e., lower autonomic arousal, profit less from psychotherapy than 
children with higher basal heart rate. In contrast, stimulant medication increases arousal, and 
it may therefore be especially useful at times of underarousal (Hermens et al., 2007; but see 
section 3.3 for more detailed information on action mechanisms). Such adaptations in the 
timing of arousal-based treatments may be particularly relevant in different ADHD subgroups 
(e.g., with or without ODD). As nighttime tachycardia has been reported in unmedicated 
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children with ADHD, this might question the use of stimulant medication that could further 
increase heart rate levels (Daniels, 2009; Hammerness et al., 2011). Though Vitiello et al. 
(2012) concluded that stimulant treatment in ADHD probably does not increase the risk for 
hypertension over a 10-year period, the persistent adrenergic effect on heart rate during 
treatment may be an important issue especially for adult’s with ADHD who are at risk due to 
higher rates of adult obesity and tobacco use (Cohen et al., 1999; Young and Bray, 2007). As 
in normal populations, an association of circadian misalignment with obesity and other 
cardiovascular risk factors has been reported, this could even further increase health risks in 
ADHD (Gangwisch, 2009; Scheer et al., 2009). 
3. LC-mediated Arousal Dysfunction in ADHD – A Working Hypothesis  
Linking Context-driven, Cognitive Energetic, and  
Context-independent Circadian-based Alterations. 
Studies to date provide a fragmented pattern of circumstantial evidence linking ADHD 
to altered circadian rhythms. A more systematic approach to studying the relationship 
between time of day effects and ADHD needs to be established and this in turn needs to be 
built on a platform underpinned by biologically and psychologically plausible models. Here 
we describe one such framework established on a working hypothesis of the biological basis 
of putative circadian disruptions in ADHD, their links to other aspects of ADHD function, 
and their biological and psychological roots. In this hypothesis we postulate that circadian 
disruptions are one aspect of a more general arousal regulation problem that has already been 
identified as the basis for a range of cognitive-energetic deficits in ADHD (Sergeant and Van 
der Meere, 1988, 1990). More specifically, we suggest an extension of models of altered 
arousal mechanisms in ADHD (Sergeant and Van der Meere, 1988, 1990) encompassing both 
cognitive energetic effects due to altered responses to changes in environmental context and 
disrupted patterns of spontaneous circadian activity across the day. Therefore in addition to 
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the pattern of findings relating to circadian effects in ADHD reported above this model is 
built on two areas of well established existing evidence. First, that LC function, as a key locus 
in noradrenergic pathways in the brain is implicated in arousal more generally and circadian 
effects specifically. Second, the evidence that arousal mechanisms are altered in ADHD 
leading to general difficulties in regulating physiological state in response to changing 
conditions. These patterns of evidence highlight the potential role of the LC disruption in 
ADHD as a biological mediator of both context specific cognitive energetic effects and 
context independent circadian effects (This model is represented in figure 1). In the following 
section, we review the literature linking LC function (and noradrenergic function more 
generally) to (i) arousal and circadian processes and (ii) ADHD pathophysiology more 
generally. We then identify areas for future research exploring the role of LC dysfunction 
specifically in relation to circadian effects in ADHD (see section 4).  
3.1. The Role of Locus Coeruleus in Arousal and Circadian Effects  
The LC, the main noradrenergic nucleus in the brain, is responsible for the regulation 
of cortical arousal which can be described as a physiological and psychological state of being 
awake, aware and alert (Aston-Jones, 2005; Samuels and Szabadi, 2008). Arousal involves 
the activation of the reticular activation system (RAS) in the brain stem, the autonomic 
nervous system and – if induced or accompanied by stress- the endocrine system (Pfaff and 
Banavar, 2007; Pfaff et al., 2007; Schwartz and Roth, 2008; Silver and LeSauter, 2008). Next 
to arousal-influencing effects of factors such as hormonal stress reactivity, emotions, 
temperament, and psychopharmacotherapy, it is assumed that arousal state regulation is also 
driven by circadian rhythms (Silver and LeSauter, 2008). A correct timing of the circadian 
clock (SCN) is important to orchestrate neural activity, regulate sleep-wake states, and control 
emotion and cognition functions (Vicentic et al., 2009).  
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The hypothesis that the LC shows fluctuations in diurnal activity has been supported 
in animals. Aston-Jones (2005) described an indirect projection from the SCN, the circadian 
pacemaker, to the LC with the dorsomedial hypothalamic nucleus (DMH) as a relay from the 
SCN to the LC. The DMH plays a major role in circadian rhythms of corticosteroid and other 
endocrine secretion, locomotor activity, and sleep (Chou et al., 2003; Germain and Kupfer, 
2008). In this SCN-DMH-LC circuit, wakefulness is induced by hypocretin/orexin 
neuropeptides activating the arousal-related LC (Ivanov and Aston-Jones, 2000), and 
inversely, suppressing the sleep-related ventrolateral preoptic areas (VLPO) (Winsky-
Sommerer et al., 2003).  
When noradrenaline (NE) is released from the LC, it exerts unique and additive wake-
promoting actions through binding on noradrenergic receptor subtypes α1 and β (please see 
Berridge and Waterhouse (2003) for a more detailed review). Such noradrenergic release in 
the cortex may produce a prolonged depolarization of cortical neurons that would increase 
their responsiveness to other inputs, for example dopaminergic prefrontal cortex (PFC) 
circuits (Gorelova et al., 2002). In contrast to α1 and β receptors that are thought to exist at 
postsynaptic sites primarily, α2  receptors can be found both pre- and postsynaptically. 
Binding of NE on the α2  receptor has sedative effects. Pre-synaptic receptors provide a local 
feedback mechanism for counteracting excessive release of NE (please see Berridge and 
Waterhouse (2003) for a more detailed review). Though clonidine, an α2  noradrenergic 
agonist, decreases LC firing (thus suppresses NE release), it enhances cognitive performance 
through binding on postsynaptic receptors in PFC (Berridge and Devilbiss, 2011). This way, 
the LC-NE system has been reported to be involved not only in (i) initiation of behavioral and 
neuronal activity ready to collect sensory information (e.g., waking), but also in (ii) 
modulation of sensory information processing, attention, and memory within the waking state 
(Berridge and Waterhouse, 2003). These behavioral processes have been associated with 
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different discharge modes of LC: The tonic noradrenergic release (i.e., spontaneous, baseline 
activity of the nucleus; which shows a circadian rhythm with an increase from sleep to waking) 
and the phasic discharge (i.e., brief, rapid increases in response to environmental stimuli when 
awake). In the latter case, phasic activation takes place in response to the processing of task-
relevant stimuli and optimalizes task performance (only possible when tonic discharge levels 
are moderately increased), whereas in the tonic mode (high levels of ongoing tonic activity), 
the LC fails to respond phasically to task demands an effect associated with poor focused 
attention and exploration (Aston-Jones and Cohen, 2005). Parallel to the Yerkes-Dodson 
relationship between arousal and performance, the authors proposed a theory stating that 
optimal performance is associated with moderate LC tonic activity and prominent phasic LC 
activation and that poor performance is associated with both low levels (inattentive, drowsy, 
sleepy) and high levels (distractible) of tonic activity, with small or even absent LC phasic 
responses. As the LC is associated with both circadian regulation and cognitive performance, 
Aston-Jones and colleagues (2001) hypothesized that circadian changes in LC activity may be 
reflected in complex task behavior, such as a circadian fluctuation in cognitive ability, next to 
alterations in sleep-wake cycles.  
3.2. ADHD, Arousal and Deficient State Regulation  
In ADHD the best evidence of arousal-related dysregulation comes from studies of the 
impact of changing environmental context on information processes. These have usually been 
interpreted in the light of state regulation deficits using cognitive energetic models (Sergeant 
and Van der Meere, 1988, 1990). Sergeant and Van der Meere (1988, 1990) first interpreted 
the non-optimal state of arousal as due to failures to appropriately allocate effort during 
information processing. In this model state dysregulation refers to an imbalance between three, 
closely linked, energetic systems, namely effort, arousal and activation. Difficulties in state 
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regulation in ADHD are predicted to arise not only from under arousal/activation but also due 
to over arousal/activation (Sonuga-Barke et al., 2010; Van der Meere, 2005).  
To date, taken from this perspective, the focus of the primary deficit in ADHD relates 
to the response preparation-related activation processes which are associated with response 
organization. In their review, Sonuga-Barke et al. (2010) point to investigation of cognitive 
performance in ADHD children during tasks with different event rates (the key probe of 
activation processes) which provide support for environmental influences on state-regulation,  
the importance of ‘optimal’ stimulation and relevance of the inverted U-curve (parallel to the 
Yerkes-Dodson relationship) linking event rate to performance via arousal/activation levels: 
during fast event rate, ADHD children responded fast and inaccurate, while during slow event 
rate, they are expected to show slow-inaccurate responding. Although there is currently little 
research on the neurobiological correlates of this deficit, a role for LC dysfunction has been 
suggested (Sonuga-Barke et al., 2010). This suggestion shifts the primary focus of interest 
from dopaminergic to noradrenergic deficits in ADHD. For a long time, the dopamine theory 
(Levy, 1991) has been the leading dogma, suggesting an inhibitory dopaminergic effect at 
prefrontal/striatal level in ADHD, which has repeatedly been supported by neuroimaging, 
genetic and stimulant medication studies (Faraone and Biederman, 1998; Faraone and Khan, 
2005; Levy and Swanson, 2001; Solanto, 1984). More recent data, however, suggest an 
important modulating role of the LC and noradrenergic arousal pathways on dopaminergic 
PFC function.  
3.3 Existing Evidence Implicating LC-related Noradrenergic Function in ADHD  
The cognitive-energetic models described above hypothesize that state regulation 
deficits are in part related to LC dysfunction (Sergeant and Van der Meere, 1988, 1990). 
Tonic activity of the LC system, located in the RAS, is associated with the regulation of 
arousal and several state-dependent processes, such as sensory information processing, 
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attention, working memory, and motor processes (Arnsten and Dudley, 2005; Devilbiss and 
Waterhouse, 2004; Sonuga-Barke et al., 2010). Below we hypothesize that the 
pathophysiology of ADHD involves an ‘overdrive’ of the LC, with excessive noradrenergic 
tonic release leading to reduced capacity of the PFC to respond to phasic stimuli (Mefford and 
Potter, 1989; Pliszka et al., 1996; Sonuga-Barke et al., 2010). More specifically, the increase 
in tonic discharge above a certain level has been associated with less robust phasic discharge 
and decrease in focused attention and increase in impulsivity (Aston-Jones and Cohen, 2005). 
Reciprocal connections between the PFC and the LC have been hypothesized by Arnsten et al. 
(1996), pointing to the role of noradrenergic in concert with dopaminergic systems in 
explaining prefrontal dysregulation (Levy and Swanson, 2001).  Studies showed that NE may 
enhance “signal/noise” processing in the PFC via actions at α2 receptors (increase signal) and 
impair its function via α1 and β receptors; these processes coincide with optimal dopamine 
(D1) stimulation (decrease noise) and excessive D1 stimulation respectively (see review 
Arnsten, 2006). Therefore, the authors suggest that catecholamines may act as a chemical 
switch: turning on PFC during normal waking and turning it off during drowsiness or stress.  
With respect to ADHD, monkey models with blockade of the α2 receptors of the PFC 
created symptoms of ADHD (hyperactivity, impulsivity, and impaired working memory), 
whereas clonidine, an α2 noradrenergic agonist used in the treatment of ADHD, has cognitive-
enhancing effects due to its ability to activate post-synaptic α2 receptors (see review Berridge 
and Devilbiss, 2011). Other treatment modalities in ADHD support (modulatory) deficits in 
noradrenergic pathways (see Berridge and Devilbiss, 2011; Biederman and Spencer, 1999; del 
Campo et al., 2011 for reviews on this topic). For example, beneficial arousal-promoting  
effects of psychostimulants are due not only to extracellular increases in dopamine but also in 
NE concentrations in the PFC (Devilbiss and Berridge, 2008).  Looking more closely at 
electrotonic coupling, on the level of the LC, low-dose administrated stimulants moderately 
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decreased the tonic discharge (which is however overcompensated by drug-induced elevations 
in extracellular NE), but largely preserved phasic signaling which is important in the 
regulation of behavioral actions (Berridge and Devilbiss, 2011). Also modafinil, an analeptic 
drug used in the treatment of narcolepsy and excessive daytime sleepiness, has been 
suggested to shift the LC to low tonic, high phasic activity which potentially enhances PFC 
function in ADHD (del Campo et al., 2011). Additionally, tricyclic antidepressants 
(noradrenergic reuptake inhibitors) have been described to be effective in the treatment of 
ADHD symptoms through an increase of extracellular NE in the PFC by blocking 
noradrenergic reuptake (Biederman and Spencer, 1999). Finally, the idea that modulation of 
noradrenergic circuits may improve ADHD symptoms is supported by the newer ADHD 
agent atomoxetine, which is also a selective inhibitor of noradrenergic transporters. Swanson 
et al. (2006) showed that atomoxetine increases NE in several brain regions including the PFC 
and dopamine in the PFC (not in other regions such as striatum and nucleus accumbens). 
Therefore, atomoxetine is assumed to have less abuse potential as compared to 
methylphenidate. The clinical use of atomoxetine has moreover been promoted in terms of its 
24-hour treatment of inattention, hyperactivity/impulsivity. Though it needs to be further 
investigated to what extent this drug modulates circadian rhythm in humans with ADHD, 
recent data suggest that atomoxetine may reset the circadian clock in mice (O’Keeffe and al., 
2012). Finally, atomoxetine is considered to be a first-line treatment in patients with comorbid 
anxiety or tics (Garnock-Jones and Keating, 2009).  
3.4. A Working Hypothesis: Circadian Effects as a Special Case of LC / Arousal 
Dysfunction in ADHD 
Based on the above review we postulate that in this case state regulation problems and 
altered circadian effects in ADHD both arise from shared origins in dysfunctional SCN-
DMH-LC pathways (see Figure 1). This hypothesis is based specifically on the idea that (i) 
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ADHD is associated with tonic hyperactivity of the LC (as described above in the state 
regulation model; Mefford and Potter, 1989; Pliszka et al., 1996; Sonuga-Barke et al., 2010), 
and (ii) that the LC itself is integrally involved in the regulation of  circadian effects generated 
by the SCN (Aston-Jones et al., 2007), next to its role in behavioral states and cognitive 
performance.  
Direct evidence for the functionality of the SCN-DMH-LC circuit comes from patients 
with a lesioned SCN who fail to modulate attention, dysregulating the timing of the attention 
focus (Cohen et al., 1997). Also with respect to hyperactivity, Sylvester et al. (2002) 
described a modulating role of SCN as suggested in studies with rats (Stephan and Zucker, 
1972). Though little techniques are available yet to detect dysfunctions of the SCN (Sylvester 
et al., 2002), clock gene polymorphisms are expected to alter the timing of the circadian 
pacemaker (Rosenwasser, 2010). With respect to ADHD, Levitan et al. (2004) suggested a 
link between polymorphisms of the 7-repeat allele of the dopamine receptor D4 gene (DRD-4), 
ADHD and circadian rhythm problems. Other authors have recently established a more direct 
link between ADHD and genetic circadian dysregulation by describing a significant 
association between polymorphisms of the 3’-untranslated region of the CLOCK gene -a gene 
previously linked to both sleep disturbances and evening preference- and ADHD (Kissling et 
al., 2008; Xu et al., 2010). Also Brookes et al. (2006) detected associations between two 
genes in the circadian rhythm system and ADHD. Very recently, Yan et al. (2011) pointed to 
additional evidence linking disruption in circadian rhythms with ADHD. In their NK1 
receptor lacking mice, resembling abnormalities in ADHD, performance varied as a function 
of time of day and for some measures of response control an interaction between NK1 
function and circadian rhythms was observed. The authors mention that this is not surprising 
as NK1R are prevalent in regions responsible for circadian control (e.g., SCN) and antagonist 
agents have been reported to cause daytime fatigue, insomnia, and disruptions of circadian 
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motor activity. On the level of DMH, lesions have also been reported to reduce circadian 
rhythms of wakefulness, locomotor activity, and cortisol levels (Chou et al., 2003). On the 
level of the LC, there is evidence for a circadian rhythm in its impulse activity and its role in 
producing transitions between sleep-waking cycles; after lesions of the LC, a decrease in the 
amplitude of the circadian rhythms in sleep-wake cycles was noted as described in reviewed 
work of Aston-Jones and colleagues (Aston-Jones et al., 2007). In their experiments, they 
additionally showed that light deprivation caused substantial decreases in noradrenergic 
neurotransmission in the rat’s frontal cortex.  
Despite the role of the LC in circadian regulation, it is currently not known whether an 
overdrive of this nucleus is specifically associated with a circadian phase delay. However, this 
hypothesis is highly plausible; Aston-Jones and colleagues hypothesized that upregulated 
noradrenergic release may contribute to both sleep (e.g., sleep onset insomnia) and behavioral 
symptomatology (e.g., daytime hyperactivity and inattention) in ADHD, as they observed 
these specific ADHD types of behavior during the tonic mode of activity in monkey LC.  
Though we assume that sleep onset problems may subsequently lead to difficulties with 
awakening and daytime sleepiness, these problems may also relate more directly to 
hyperactive tonic discharge of the LC. With respect to morning awakening, an increase in 
tonic activity is needed for transition from sleep to wake. High baseline levels are however 
associated with less variability (Phillips et al., 2000) (see section 4.1.b; pupil diameter), which 
may hypothetically impede such transitions. During wake, changes in the tonic and 
subsequently phasic activity of the LC have been associated with fluctuations in alertness 
under specific conditions (Aston-Jones, 2005). As in our review above it was noted that 
ADHD behavior  becomes more overt at specific times of day, it is reasonable to hypothesize 
that the two functions of the LC - its role in both state control and performance- interact and 
that ‘baseline LC hyperarousal’ in ADHD leads to a complex profile of circadian-regulated 
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and context-dependent behavioral dysregulation. It still needs to be determined though how 
time of day effects would interact with the expression of the tonic/phasic mode of LC activity 
–or transitions between them- to affect prefrontal functioning.  
INSERT FIGURE 1 ABOUT HERE 
Though highlighting the link between circadian alterations and ADHD may allow us 
to identify novel processes for study in ADHD, the complexity of the working hypothesis 
presented above must be recognized (see Figure 1). First, neurotransmitter systems do not 
operate independently, and the interaction between NE, dopamine, and serotonin is probably 
important in psychopathology (Harvey et al., 2011). In addition to the noradrenergic circuitry 
described above, dopaminergic and serotonergic dysfunctions may additionally link circadian 
alterations to ADHD as these neurotransmitters are themselves influenced by the circadian 
rhythm system and considered to be pathophysiologically involved in ADHD (Faraone and 
Khan, 2005; Levy, 2009; Paclt et al., 2005; Pattij and Vanderschuren, 2008; van der Kooij 
and Glennon, 2007). Second, complex interactions between neurotransmitters, clock genes, 
and circadian neurobiological structures have been described. For example, Barnard and 
Nolan (2008) refer to the fact that clock gene expression is modulated by neurotransmitter 
effects. The circadian clock has also been described to be influenced by an ‘overdrive’ of the 
LC and related increase in noradrenergic activity (Maurizi, 1984) such as seen in ADHD. This 
could be due to inadequate noradrenergic stimulation of the pineal gland, altering the 
concentrations of its main hormonal product melatonin, which in turn is important in the 
regulation of the circadian clock containing melatonin receptors (Pacchierotti et al., 2001). 
Finally, the idea that circadian alterations are an expression of ADHD-related arousal-based 
problems is probably only valid for a specific subsample of subjects with ADHD, and may 
also be present in other psychiatric disorders. This hypothesis is in line with for example 
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findings that executive functioning deficits and delay aversion are implicated in ADHD, 
though that neither is necessary for ADHD nor specific too it (Sonuga-Barke et al., 2008).  
4. Proposals for Future Study of Circadian Effects in ADHD  
In this section we discuss future directions for research indicated by the LC-based 
model of circadian effects described above and described in Figure 1. Multilevel 
interdisciplinary research will be necessary to address the current gaps in this research area. 
At this point, there is evidence for a link between ADHD, dysregulated arousal and LC, and a 
link between LC and circadian rhythms (described above). More systematic research however 
is needed to investigate circadian-related effects in ADHD to confirm currently available 
findings presented in the review.  
Based on the model proposed above, we formulate the following predictions: (i) 
ADHD is associated with LC-mediated circadian rhythm alterations; subpredictions are: (a) 
LC tonic hyperactivity in ADHD is more expressed at specific times of day than others; (b) 
there is a disruption in the circadian rhythms of LC-noradrenergic mediated arousal in ADHD; 
(c) subjects with ADHD show specific alterations in behavioral and physiological measures as 
a function of time of day; (d) circadian disruptions in LC activity, arousal, and behavioral/ 
physiological measures will be correlated in ADHD; (ii) there is an interaction of time of day 
effects and specific environmental stimuli suggesting a ‘shared LC state-regulation pathway 
deficit’ in ADHD; and (iii) the theory of disrupted circadian rhythms is probably only valid 
for a subgroup of cases with ADHD and may overlap with other psychiatric conditions. 
4.1. Prediction 1: ADHD is Associated with LC-mediated Circadian Rhythm Alterations 
a. LC tonic hyperactivity in ADHD is more expressed at specific times of day than 
others.  
ADHD has been associated with an ‘overdrive’ of the LC (Mefford and Potter, 1989; 
Pliszka et al., 1996; Sonuga-Barke et al., 2010), which is in turn involved in the circadian 
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regulation of arousal and sleep-wake states (Aston-Jones et al., 2007). These findings rely 
heavily on animal studies, but it is reasonable –though still challenging- to investigate the LC 
in humans with ADHD and to detect whether the LC dysfunction in ADHD is circadian 
sensitive. One way to do so is the use of neuroimaging methods, such as functional magnetic 
resonance imaging (fMRI) and positron emission tomography (PET). To address this question 
imaging procedures need to be repeated across a 24-hour period. During daytime hours, this 
has been done before not only for visualization of circadian activity in the LC but also in the 
SCN (Schmidt et al., 2009), when subjects were exposed to different environmental 
stimulus/task conditions at different times of day. Scanning during sleep will be cumbersome 
but is theoretically feasible. However, practical problems may arise as it is difficult to fall 
asleep during scanning procedures. A PET protocol to study sleep in a naturalistic setting has 
been provided, though with decreased temporal resolution (Nofzinger et al., 1998). In this 
regard, less invasive, peripheral arousal measures and electroencephalogram (EEG) (as 
described in the second and third subprediction) may be interesting to (additionally) study 
sleep in humans.  
Pharmacological studies also allow investigation of the LC function and activity. For 
example, studies with clonidine used for ADHD or as an anesthetic have provided in-depth 
knowledge on sleep-wake and cognition regulatory functions through the study of binding on 
pre- and postsynaptic α2 adrenergic receptors (see for reviews: Arnsten et al., 1996; Berridge 
and Devilbiss, 2011). Another example relates to disruption of circadian rhythms in 
dopaminergic concentration and receptor activity which have been linked to circadian 
symptomatology in drug addiction (Falcon and McClung, 2009; Naber et al., 1980; Sleipness 
et al., 2007). In their review, Manev and Uz (2009) reported time-dependent behavioral 
actions of both cocaine and amphetamines. In relation to noradrenergic receptors, circadian 
rhythms are thought to be modified by tricyclic antidepressants (Wirz-Justice et al., 1980). It 
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will be valuable to explore time-dependent effects on ADHD drugs’ working mechanisms 
considering both dopaminergic and noradrenergic pathways. Such knowledge could guide 
more systematic effect-evaluation studies taking into account time of day effects of different 
drug-releasing modalities for ADHD (Swanson et al., 2004) to treat time-specific arousal 
problems in this population (see prediction 2).  
b. There is a disruption in the circadian rhythms of LC-noradrenergic mediated 
arousal in ADHD. 
 In recent research, the utility of two candidate psychophysiological markers of LC-
noradrenergic activity has been investigated: the P3- event related potential (ERP) and pupil 
diameter (Murphy et al., 2011). The P3 is an ERP component peaking 300-600 ms after a 
task-relevant stimulus, which has been argued to represent a cortical electrophysiological 
correlate of the phasic LC response and the noradrenergic potentiation of information 
processing (Nieuwenhuis et al., 2005). A second index is pupil diameter, an autonomic 
measure involving both sympathetic and parasympathetic activity, which has been 
hypothesized to reflect both tonic and phasic aspects of LC activity. More specifically, 
upregulation of tonic noradrenergic activity has been associated with increases in baseline 
pupil diameter and decrease in pupillary variability, while pupil dilatory response occurs to a 
wide range of task-related stimuli (Phillips et al., 2000).  
To confirm the circadian-related prediction above, it would be necessary to assess 
baseline pupil diameter at different times of the day in both cases with and without ADHD. 
Because of the close relation between tonic and phasic activity in daytime cognitive 
performance it is important to detect whether ADHD-associated increases in tonic activity 
(and therefore larger pupil diameter baseline) are more expressed at different times of the day. 
With respect to the P3, which is assumed to reflect phasic activity, amplitudes have often been 
found to be smaller in ADHD as compared to controls (Barry et al., 2003b). There is evidence 
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that P3 differences in ADHD are related to arousal states: for example, in their event rate 
study, Wiersema et al. (2006a; 2006b) found altered P3 components in the ADHD as 
compared to a control group only when in underaroused state. However, as of yet, no study 
has evaluated time of day effect on P3 deviation in ADHD. Suggestions to investigate the 
circadian-environmental overlap are discussed in prediction 2.    
Though pupillometry is often used in research on daytime sleepiness (decreased pupil 
size due to parasympathetic influence) under both light and darkness conditions, 
measurements can not be made “during” sleep. With respect to P3, small or even absent 
potentials are expected during sleep as low tonic firing rate does not allow phasic discharge. 
Though studies analyzing auditory input during sleep observed a sleep P3, it is uncertain to 
what extent this potential is equivalent to waking P3 (Bastuji et al., 2002). Nevertheless, 
further investigation of the role of the LC in regulating autonomic nervous system and sleep-
wake cycles is important as fluctuations in a variety of measures of “arousal state” (e.g., heart 
rate) have been reported to affect P3 morphology (Polich and Kok, 1995). Such peripheral 
measures may provide an excellent alternative to monitor arousal states during both night and 
day (see also description in prediction 1c): Nieuwenhuis et al. (2011) described in their review 
that changes in LC activity are not only highly correlated with changes in P3 component and 
pupil diameter, but also in skin conductance level and heart rate.  
Alternatively, EEG is very suitable for this purpose as it is a direct index of the 
electrical activity of the brain. More specifically, the θ/β ratio and α power in the EEG signal 
have been used as a marker of central nervous system arousal. In ADHD, higher θ/β and α 
deviances have been argued as an indication of cortical underarousal (see Barry et al. (2003a) 
for a review). As of yet, there are no studies that evaluated time of day effects for these EEG 
deviances. MSTL represents another option for the evaluation of daytime sleepiness and PSG 
for more micro-evaluation of wake-sleep transitions and nighttime awakenings. 
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c. Subjects with ADHD show specific alterations in behavioral and peripheral 
physiological measures of arousal as a function of time of day. 
Though behavioral and physiological measures of arousal have value in the evaluation 
of 24-hour patterns, studies evaluating these effects in ADHD have mostly been confounded 
so far. Suggestions to address the issue of sample heterogeneity are discussed in prediction 3. 
To control for environmental confounding effects, laboratory protocols have been developed 
for circadian evaluations. The constant routine protocol controls for possible exogenous 
factors in order to avoid their masking influences on the endogenous rhythm of the measured 
variables. In this protocol, both contextual factors, such as light, feeding and activity, and 
circadian measurement conditions are strictly regulated (Atkinson et al., 2007; Bailey and 
Heitkemper, 2001; Blatter and Cajochen, 2007; Scheer et al., 2003). However, this 
methodology not only raises financial, practical and ethical issues, especially in children, but 
also the ecological validity of such procedure is questionable. Therefore, longer-term 
evaluations in naturalistic settings, including multiple ‘combined’ measurements across 
several days, are required (Houtveen and de Geus, 2009). As an extension to previous 
research, we propose a longer term ‘combined’ approach that may include  the assessment of 
environmental information (e.g., lights out, daily activities), subjective and objective  
sleep/wake assessments during several days and nights (e.g., actigraphy, DLMO, MSLT, 
PSG), in addition to a ‘full’ circadian cortisol investigation (several measurements a day), 24-
hour registration of heart rate (with simultaneous ‘control’ measurement of activity), and 
alternative measures which so far have not been carried out in ADHD. Useful alternative 
measures could be for example blood pressure (Houtveen and de Geus, 2009), skin 
conductance (Hot et al., 1999) and body temperature (Bailey and Heitkemper, 2001; Hofstra 
and de Weerd, 2008). It must be noted however that some measures, for example of body 
temperature, are probably not feasible in children as it is a relatively invasive procedure. 
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Finally, heart rate variability and spectral analysis of this measure are today one of the best 
methods to follow the activity of autonomic nervous system and its differential influences of 
the ortho- and parasympathetic branches during night.  
d. Circadian disruptions in different arousal-related measures (LC, arousal, and 
behavioral/ physiological measures) will be highly correlated in ADHD. 
Based on our working hypothesis, we expect that circadian effects on different 
arousal-related measures will be highly correlated within participants with ADHD. However, 
if circadian discrepancies between measures exist, this may reveal subtle differences in 
underlying neural processes. For example, when studying the circadian SCN-DMH-LC circuit, 
DMH lesions appear to eliminate circadian rhythms of corticosteroids but not melatonin 
(Chou et al., 2003). These authors hypothesize that a ‘combined’ disruption of cortisol and 
melatonin rhythm may be originated in the SCN –which is highly sensitive to melatonin 
input- rather than the DMH as other studies lesioning DMH and regions outside the DMH 
found circadian alterations in both measures.  
Examination of the correlation between peripheral and more fundamental measures is 
also warranted. Schmidt et al. (2009) studied the influence of circadian and homeostatic 
processes on cognitive performance in different chronotypes (morning vs evening) by 
imaging the LC and SCN (fMRI) during performance-related tasks (reaction times) at two test 
sessions (morning vs evening). Participants were also monitored by PSG at their preferred 
bedtimes during two consecutive nights; combined with assessments of subjective sleepiness, 
objective vigilance, and hourly collected saliva samples for assessment of melatonin phase 
starting 7 hours prior to habitual sleep time. Such a protocol might be adapted (oddball 
performance tasks) and extended with, for example, P3 ERP evaluation or pupil diameter 
response as these measures have been  associated with information processing, reflecting 
phasic activity of the LC-noradrenergic system (Nieuwenhuis et al., 2005). 
CIRCADIAN PROFILES IN ADHD  43 
 
In our literature review some studies suggested a circadian phase delay in ADHD. 
Normally, during sleep and drowsiness there is low tonic activity, whereas tonic activity is 
increased when one is alert (Aston-Jones and Cohen, 2005). If a circadian delay is truly 
present in ADHD, following this reasoning this would mean relatively low tonic LC activity 
in the morning and relatively high tonic LC activity in evening. These deviations would both 
lead to non optimal performance: in the morning reflected by inattentive, drowsiness and 
being non-alert, in the evening by distractibility (see model Aston-Jones, page 406 in Aston-
Jones & Cohen, 2005). At this point, it is difficult to say what phasic indices of LC will do, as 
during both (too) low and high tonic LC activity, phasic responses will be diminished (as can 
be measured by P3 component, pupil diameter response). In terms of baseline tonic LC 
activity, a smaller pupil diameter in the morning, but larger in the evening would be predicted.  
4.2. Prediction 2: There is an Interaction of Time of Day Effects and Specific 
Environmental Stimuli Suggesting a ‘Shared LC State-regulation Pathway Deficit’ in 
ADHD 
From a more theoretical perspective, current task protocols could be used at different 
times of the day to investigate the influence of arousing environmental stimuli on state 
regulation deficits in ADHD to see whether these results fluctuate across the day. In his study 
with NK1R-lacking mice, Yan et al. (2011) explicitly included the time of day during which 
mice were trained and tested. Based on their findings, the authors suggested that “time of day 
might be a key variable in studies of ADHD patients and that the effect of an interaction 
between NK1R function and circadian rhythms on response control merits further 
investigation.” A concrete test of the interaction of time of day and environmental effects of 
arousal could be performed using event rate effects during different times of day, for example 
morning versus afternoon. Therefore, we additionally recommend longer-term evaluations of 
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ADHD behavior (both quantitative and qualitative) in different contexts or under different 
environmental conditions.  
One context of interest would refer to the lab school protocol that is used in 
medication effect evaluation studies so far. This quasi-experimental naturalistic setting allows 
for the combined registration of behavior and additional measures (e.g., heart rate, saliva 
sampling) under different context conditions (e.g., academic tasks, free play) controlling for 
possible time of day effects. Though such protocols typically include ADHD children during 
summer camps, comparison with typically developing children would be interesting to detect 
during which specific situations and times of day group differences become more overt. This 
information would be very useful in the further evaluation of medication effects to treat 
problematic behavior especially at times when it is more expressed (Chavez et al., 2009; 
Pelham et al., 2001; Sonuga-Barke et al., 2004; Swanson et al., 2004).  
Another context of relevance is stress. Though arousal is closely related to stress, Pfaff 
et al. (2007)  provided a framework to understand the asymmetric relation between stress and 
arousal mechanisms, suggesting that stimuli causing stress are theorized to cause arousal, but 
inversely, that not all stimuli causing arousal are stressful. Whereas autonomic responses (e.g., 
heart rate) are activated in both stressful and non-stressful arousal conditions, the HPA axis 
(e.g., cortisol) is only activated in stressful conditions. Therefore, the combined diurnal 
assessment of heart rate and cortisol in diurnal evaluations could further explore to what 
extent underlying hypotheses relating time of day effects in arousal are specific for ADHD or 
whether they are the product of a more general stress-related dysregulation.  
4.3. Prediction 3: The Association with Circadian Rhythm is Only Valid for a Subgroup 
of ADHD and May Overlap with Other Psychiatric Conditions 
Considering the heterogeneous nature of ADHD, it seems necessary to determine 
whether alterations in peripheral measures and underlying pathways, if confirmed in ADHD, 
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are specific for some cases with the disorder or to what extent sleep-wake disruptions reflect a 
transdiagnostic phenomenon relevant across psychiatric disorders. Therefore, we suggest that 
future research should account for confounding effects related to age and sex characteristics, 
but also to ADHD subtype, ADHD severity, comorbidity with externalizing disorders (ODD, 
CD),  internalizing disorders (anxiety, depression), or sleep disorders, and use of (stimulant) 
medication. One could aim to study homogeneous clinical samples, but -what may be even 
more fascinating- would be the use of a large-scale heterogeneous sample and a search for 
specific subgroups of patients with circadian dysregulation. Cases with ADHD and sleep-
wake problems and cases with executive function (state regulation) deficit problems would be 
especially interesting to study. ADHD subgroups may be differentially affected by time of 
day effects; however, some may show eveningness chronotypology to inattention problems 
(Caci et al., 2009), whereas others reported the combined group to be more vulnerable for 
circadian problems (Chiang et al., 2010).  
5. Conclusion 
In line with evidence in other psychiatric disorders, the current literature provides 
some initial evidence of at least a subgroup of children with ADHD with circadian problems. 
Considering the heterogeneous nature of the disorder, it is plausible that anomalies related to 
one or more circadian measures reflect a distinct subgroup. Though it is not clear to what 
extent these problems are specific for ADHD at this stage, available evidence suggests that 
the circadian rhythm disruptions can at least modify severity and outcome, and may in some 
cases play a more etiological role. Although pathophysiological theories on ADHD so far 
largely ignored circadian effects on arousal and ADHD symptomatology, developing 
knowledge in several circadian domains, including underlying neurobiological mechanisms, 
led us to propose a working hypothesis that could serve as a framework for further research. 
In this putative model ADHD-related disruption of circadian processes and context-specific 
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effects on arousal-related processes such as cognitive energetic deficits are hypothesized to be 
the result of LC dysfunction. Here we review the potential implications of this model for 
clinical practice and future research.  
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